{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319812668032.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.gastro.2010.01.042"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508510001484?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508510001484?httpAccept=text/plain"}}],"dc:title":[{"@value":"Carriers of Inactive Hepatitis B Virus Are Still at Risk for Hepatocellular Carcinoma and Liver-Related Death"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319812668162","@type":"Researcher","foaf:name":[{"@value":"Jin–De Chen"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668032","@type":"Researcher","foaf:name":[{"@value":"Hwai–I. Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668036","@type":"Researcher","foaf:name":[{"@value":"Uchenna H. Iloeje"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668034","@type":"Researcher","foaf:name":[{"@value":"San–Lin You"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668033","@type":"Researcher","foaf:name":[{"@value":"Sheng–Nan Lu"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668160","@type":"Researcher","foaf:name":[{"@value":"Li–Yu Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668164","@type":"Researcher","foaf:name":[{"@value":"Jun Su"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668035","@type":"Researcher","foaf:name":[{"@value":"Chien–An Sun"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668161","@type":"Researcher","foaf:name":[{"@value":"Yun–Fan Liaw"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319812668163","@type":"Researcher","foaf:name":[{"@value":"Chien–Jen Chen"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00165085"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00165085"}],"prism:publicationName":[{"@value":"Gastroenterology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2010-05","prism:volume":"138","prism:number":"5","prism:startingPage":"1747","prism:endingPage":"1754.e1"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0016508510001484?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0016508510001484?httpAccept=text/plain"}],"createdAt":"2010-01-29","modifiedAt":"2025-09-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002215482011904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142418892032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual Agonist of Farnesoid X Receptor and Takeda G Protein‐Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693322566144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Novel monitoring of hepatitis B reactivation based on ultra‐high sensitive hepatitis B surface antigen assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285712468909440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Associations of HLA-DP Variants with Hepatitis B Virus Infection in Southern and Northern Han Chinese Populations: A Multicenter Case-Control Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617829657088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640256779904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656191275648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447135488","@type":"Article","resourceType":"other","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"7. Cutting Edge of the Treatment for Viral Hepatitis"},{"@language":"ja","@value":"7．ウイルス性肝炎の治療の進歩"},{"@value":"教育講演 ウイルス性肝炎の治療の進歩"},{"@language":"ja-Kana","@value":"キョウイク コウエン ウイルスセイ カンエン ノ チリョウ ノ シンポ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679770642688","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of hepatocellular carcinoma after seroclearance of hepatitis surface antigen"},{"@language":"ja","@value":"ＨＢｓ抗原陰性化後に肝細胞癌を発症したＨＢＶキャリア症例"},{"@value":"症例報告 HBs抗原陰性化後に肝細胞癌を発症したHBVキャリア症例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク HBs コウゲン インセイカ ゴ ニ カン サイボウガン オ ハッショウ シタ HBV キャリア ショウレイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390865806744558592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up"},{"@value":"A Case of Chronic Hepatitis B in which HBs Antigen Seroclearance was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.gastro.2010.01.042"},{"@type":"CROSSREF","@value":"10.1007/s12072-017-9799-9_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1002/hep.31712_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1111/liv.13349_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0024221_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.2957/kanzo.52.176_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1111/hepr.13552_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.3643-24_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1273-2_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1229-6_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"},{"@type":"CROSSREF","@value":"10.2169/naika.101.2681_references_DOI_FHMx4oeSJchgZcgE23igzddqRVO"}]}